Chief Scientific Officer. Cannabinologist
Ecovita Health Corp, Evitrade Health Systems
The Department of Pharmacology was established at UBC in 1951. A Therapeutics division was subsequently added to add focus to evidence based drug therapy. Recently, the department merged with Anesthesiology to foster interactions between basic and clinical scientists. Faculty members in the department of Anesthesiology, Pharmacology & Therapeutics are engaged in research in areas of neural, cardiovascular, respiratory and clinical pharmacology as well as drug development. Exceptional students with an undergraduate degree may be admitted directly into the Ph.D. program. Some students do a combined M.D./Ph.D. program for which a separate admission into the M.D. program, by the Faculty of Medicine, is required. Students pursuing a Ph.D. will have the opportunity to interact with basic as well as clinical scientists.
The shared research interests in anesthesiology, pharmacology, drug development and therapeutics allow students to gain broad-based exposure to fundamental as well as medically-related aspects of drug research. Research projects in the department are funded by operating grants from CIHR, NSERC, The Heart Foundation, etc. In addition, many of our students receive the highly competitive CIHR and NSRC studentship awards.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Overall score requirement: 100
Overall score requirement: 7.0
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
The GRE is not required.
All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,698.56||$2,984.09|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$969.17 (approx.)|
|Costs of living (yearly)||starting at $17,242.00 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
All full-time students who begin a UBC-Vancouver PhD program in September 2018 or later will be provided with a funding package of at least $18,000 for each of the first four years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. Please note that many graduate programs provide funding packages that are substantially greater than $18,000 per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.
Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their direction. The duties usually constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is a form of financial support for a period of graduate study and is, therefore, not covered by a collective agreement. Unlike other forms of fellowship support for graduate students, the amount of a GRA is neither fixed nor subject to a university-wide formula. The stipend amounts vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded. Some research projects also require targeted research assistance and thus hire graduate students on an hourly basis.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
23 students graduated between 2005 and 2013. Of these, career information was obtained for 19 alumni (based on research conducted between Feb-May 2016):
These statistics show data for the Doctor of Philosophy in Pharmacology (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
|2017||Dr. Kim studied the mechanisms of an emerging class of therapeutics used for the treatment of epilepsy. His research revealed critical molecular interactions between a drug named retigabine and potassium channel proteins in the brain. These novel findings will contribute to the development of more effective therapies in the future.|
|2017||Dr. Osei assessed cell communication within the airways of asthmatic and COPD patients. His work showed the importance of Interleukin-1 alpha in the mediation of inflammation and fibrosis. This work increases our knowledge in chronic inflammation and remodelling that occurs in asthma and COPD, and provides avenues for new therapeutic research.|
|2017||Dr. Sellers studied the vascular biology of Marfan syndrome with a focus on understanding how current therapies work and finding new potential drug targets. Her work helps to better understand Marfan syndrome and provide the basis upon which to design new treatments for patients in the future.|
|2016||Dr. Baimel studied how orexin neurons modulate the activity of dopamine neurons in the reward circuitry of the brain. He determined that orexin gates addictive-drug induced changes in subpopulations of these neurons. This knowledge adds to our understanding of how addictive drugs alter the brain and may aid in the search for novel treatments.|
|2016||Dr. Trane characterized a novel therapeutic target by studying the interaction between two proteins found in blood vessels involved in heart disease development. His work will hopefully help create new drugs that can be used to treat cardiovascular problems such as stroke, heart attacks and high blood pressure.|
|2015||Dopamine is a chemical in the human brain that is important for decision making. Dr. Pitman investigated how dopamine is regulated and what impact obesity has. She found that the mechanisms responsible for reducing dopamine release were not affected by obesity. Her work contributes to understanding how obesity can alter the decisions that we make.|
|2015||Dr. Leung showed the new functional roles of two proteins, myoferlin and dysferlin, in normal lungs and in lung cancer. She found that myoferlin plays an important role in the growth and metastasis of lung cancer. Her work identifies the necessity of targeting myoferlin, to prevent the development of lung cancer and prolong the lifespan of patients.|
|2015||Dr. Sharma conducted research into blood vessels in UBC's Department of Pharmacology. She investigated the protective effects of a novel protein that improves blood vessel function and reduces atherosclerosis, a disease in which plaque builds up in the blood vessels. Her findings suggest an alternate treatment strategy for cardiovascular disease.|
|2015||Dr. Leung's research focused on cardiovascular complications of diabetes. She investigated potential factors that influence contractile functions of the heart and blood vessels in both type 1 and type 2 diabetes. Her results provide important insights on how specific drugs can improve cardiovascular performance in the diabetic population.|
|2014||Dr. Wong studied the blood pressure lowering effects of beta blockers, which are used to treat chest pain. He showed that different sub-types of beta blockers lower blood pressure by different amounts and generally have no effect on pulse pressure. His research provides new information to assist physicians and patients in clinical decision-making.|
Pharmacology offers training in cardiovascular pharmacology, neuropharmacology, viral pharmacology, free radical biology, and drug development. Additional training programs exist in therapeutics, evidence-based medicine, and clinical investigation which reflecting the close association between the disciplines of anesthesiology, pharmacology, and therapeutics.